GREENWAVE TECHNOLOGY SOLUTIO (GWAV)

US57630J4031 - Common Stock

0.3209  -0.02 (-6%)

After market: 0.3186 0 (-0.72%)

Fundamental Rating

2

Taking everything into account, GWAV scores 2 out of 10 in our fundamental rating. GWAV was compared to 84 industry peers in the Commercial Services & Supplies industry. The financial health of GWAV is average, but there are quite some concerns on its profitability. GWAV is valued expensive and it does not seem to be growing.



1

1. Profitability

1.1 Basic Checks

In the past year GWAV has reported negative net income.
In the past year GWAV has reported a negative cash flow from operations.
In the past 5 years GWAV reported 4 times negative net income.
GWAV had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

GWAV's Return On Assets of -140.15% is on the low side compared to the rest of the industry. GWAV is outperformed by 98.81% of its industry peers.
Looking at the Return On Equity, with a value of -186.50%, GWAV is doing worse than 88.10% of the companies in the same industry.
Industry RankSector Rank
ROA -140.15%
ROE -186.5%
ROIC N/A
ROA(3y)-73.03%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

GWAV has a Gross Margin of 35.74%. This is in the better half of the industry: GWAV outperforms 63.10% of its industry peers.
In the last couple of years the Gross Margin of GWAV has declined.
The Profit Margin and Operating Margin are not available for GWAV so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 35.74%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-25.95%
GM growth 5Y-16.49%

5

2. Health

2.1 Basic Checks

GWAV does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for GWAV has been reduced compared to 1 year ago.
Compared to 5 years ago, GWAV has less shares outstanding
GWAV has a worse debt/assets ratio than last year.

2.2 Solvency

GWAV has an Altman-Z score of -8.74. This is a bad value and indicates that GWAV is not financially healthy and even has some risk of bankruptcy.
GWAV's Altman-Z score of -8.74 is on the low side compared to the rest of the industry. GWAV is outperformed by 95.24% of its industry peers.
A Debt/Equity ratio of 0.09 indicates that GWAV is not too dependend on debt financing.
GWAV's Debt to Equity ratio of 0.09 is fine compared to the rest of the industry. GWAV outperforms 76.19% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF N/A
Altman-Z -8.74
ROIC/WACCN/A
WACC6.53%

2.3 Liquidity

GWAV has a Current Ratio of 2.10. This indicates that GWAV is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of GWAV (2.10) is better than 69.05% of its industry peers.
GWAV has a Quick Ratio of 2.01. This indicates that GWAV is financially healthy and has no problem in meeting its short term obligations.
GWAV has a better Quick ratio (2.01) than 78.57% of its industry peers.
Industry RankSector Rank
Current Ratio 2.1
Quick Ratio 2.01

3

3. Growth

3.1 Past

The earnings per share for GWAV have decreased strongly by -9499.78% in the last year.
Looking at the last year, GWAV shows a small growth in Revenue. The Revenue has grown by 5.58% in the last year.
The Revenue has been growing by 346.94% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-9499.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-4090%
Revenue 1Y (TTM)5.58%
Revenue growth 3Y1427.89%
Revenue growth 5Y346.94%
Sales Q2Q%-16.33%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. Valuation

4.1 Price/Earnings Ratio

GWAV reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for GWAV!.
Industry RankSector Rank
Dividend Yield N/A

GREENWAVE TECHNOLOGY SOLUTIO

NASDAQ:GWAV (11/18/2024, 8:00:01 PM)

After market: 0.3186 0 (-0.72%)

0.3209

-0.02 (-6%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap6.49M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -140.15%
ROE -186.5%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 35.74%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.45
Health
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 2.1
Quick Ratio 2.01
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)-9499.78%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next YN/A
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)5.58%
Revenue growth 3Y1427.89%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y